• Nenhum resultado encontrado

[PDF] Top 20 Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Has 10000 "Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer." found on our website. Below are the top 20 most common "Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.".

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

... achieved in the management of NSCLC, identification of specific molec- ular criteria is still a challenge to increase response rates ...[14]. In the present study, we analyzed ... See full document

9

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data

... Lung cancer leads cancer-related mortality worldwide. Non-small-cell lung cancer (NSCLC), the most prevalent subtype of this recalcitrant ... See full document

11

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

BRCA1: a novel prognostic factor in resected non-small-cell lung cancer.

... early-stage non-small-cell lung cancer (NSCLC) is considered a potentially curable disease following complete resection, patients have a wide spectrum of survival ... See full document

7

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.

Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.

... prognostic factor in multivariate ...maldistribution of dichotomy and tiny sample size of low albumin level, high neutrophil level and grade3 ...for patients initially diagnosed as ... See full document

14

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.

Gefitinib inhibits invasive phenotype and epithelial-mesenchymal transition in drug-resistant NSCLC cells with MET amplification.

... Despite the initial response, all patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) eventually develop ... See full document

13

Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.

Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.

... is of great importance for genome integrity and plays a crucial role in cancer initia- tion and ...ations in the TERT gene as risk factors for many cancer types ...studies ... See full document

13

Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR.

Fibroblast growth factor receptor 1 amplification in non-small cell lung cancer by quantitative real-time PCR.

... Collection of biospecimens and outcomes data complied with the Helsinki Declaration and was approved by the Wayne State University School of Medicine Institutional Review ...used ... See full document

8

Potential role of immunotherapy in advanced non-small-cell lung cancer

Potential role of immunotherapy in advanced non-small-cell lung cancer

... ushered in a new era with respect to the treatment of advanced non-small-cell lung ...Many patients are not suitable for treatment with epidermal ... See full document

10

Einstein (São Paulo)  vol.13 número2

Einstein (São Paulo) vol.13 número2

... report the demographic data and clinical outcomes of non-small-cell lung cancer patients exposed to erlotinib in any line of ...study of ... See full document

6

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice

... development of new diagnostic, prognostic and predictive markers could significantly enhance its early detection ...from the Collaborative Advanced Stage Tissue Cancer (CASTLE) network are ... See full document

13

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Baseline and Trend of Lymphocyte-to-Monocyte Ratio as Prognostic Factors in Epidermal Growth Factor Receptor Mutant Non-Small Cell Lung Cancer Patients Treated with First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

... important role in tumor eradication[11] and macrophages are associated with tumor progression[12, 13], we presumed that patients with higher lymphocyte- to-monocyte ratio (LMR) might ... See full document

13

Clinics  vol.67 número11

Clinics vol.67 número11

... read the recent article by Bacchi et al. in a recent issue of your esteemed journal with great interest ...(1). The article is highly thought provoking. Over the past few years, ... See full document

1

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells.

... Epidermal growth factor receptor (EGFR), member of the human epidermal growth factor receptor (HER) family, plays a critical role in regulating multiple cellular ... See full document

22

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

THROMBOCYTOSIS AS PROGNOSTIC FACTOR FOR SURVIVAL IN PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER TREATED WITH FIRST- LINE CHEMOTHERAPY.

... Firstly the increase in platelet count may promote tumor cells growth and ...including vascular endothelial growth factor (VEGF) and platelet- derived growth ... See full document

5

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.

... is the formation of new blood vessels from the endothelium of existing vasculature, plays a pivotal role in tumor growth, progression and metastasis ...series of ... See full document

14

PDF PT Jornal Brasileiro de Pneumologia 1 1 portugues

PDF PT Jornal Brasileiro de Pneumologia 1 1 portugues

... Uma análise do estadiamento internacional para o câncer do pulmão, utilizado mundialmente nos últimos dez anos, mostrou problemas em duas áreas. O primeiro problema diz respeito ao mapa dos linfonodos mediastinais criado ... See full document

2

PDF EN Jornal Brasileiro de Pneumologia 8 1 english

PDF EN Jornal Brasileiro de Pneumologia 8 1 english

... associated with the development of lung ...is of funda- mental importance for the understanding of the genetic programming involved in the onset and ... See full document

2

Braz. j. .  vol.81 número1

Braz. j. . vol.81 número1

... Tumors whose paraffin blocks were located and contained enough material for new sections were included in the survey. We required adequate tissue and data for stag- ing each lesion by its tumor location, ... See full document

5

J. bras. pneumol.  vol.35 número8 en v35n8a01

J. bras. pneumol. vol.35 número8 en v35n8a01

... for the development of the tumor. In both cases, the hereditary component is determinant, since it confers a greater genetic predisposition to the ...to lung ... See full document

2

J. bras. pneumol.  vol.42 número5

J. bras. pneumol. vol.42 número5

... Objective: Lung cancer is a global public health problem and is associated with high ...mortality. Lung cancer could be largely avoided by reducing the prevalence of ... See full document

9

Show all 10000 documents...